The legalization of recreational marijuana in Minnesota has created daily conversations about how to incorporate the use of ...

Lowered costs and incremental effectiveness could improve when using biomarker-guided selection for treatment of patients ...

Mirvetuximab soravtansine showed high evidence of efficacy in heavily pretreated FRα-positive, platinum-sensitive ovarian ...

Researchers say machine learning advances make it possible to use more sophisticated body composition analyses to assess risk ...

Clinical research presented at the European Society for Medical Oncology Congress 2024 highlights the significant survival benefits of perioperative and neoadjuvant immunotherapy with nivolumab and ...

While neoadjuvant therapy in stage III or great melanoma is already the standard of care, new research presented at ESMO ...

Navigating New Frontiers: Bruton Tyrosine Kinase Inhibitors in Chronic Spontaneous Urticaria Treatment ...

Enfortumab vedotin showed a robust disease control rate in patients with urothelial cancer outside of a clinical trial, and ...

Sheela Rao, MBBS, FRCP, MD, consultant medical oncologist at the Royal Marsden Hospital, discussed the findings of the POD1UM ...

Disparities continue in younger patients, raising the need for novel interventions to mitigate challenges associated with ...

Undetectable measurable residual disease rates can help predict progression-free survival in patients with chronic ...

The National Comprehensive Cancer Network Policy Summit emphasized the importance of integrating diversity, equity, and ...